secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0000950170-24-063565
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TMCI stockholders re-elect directors and approve executive compensation at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected John K. Bakewell (39.1M for), Richard W. Mott (40.2M for), John T. Treace (44.0M for) as Class III directors.
- Advisory vote on executive compensation approved: 44.8M for, 4.0M against, 13.9K abstain.
- Stockholders favored holding Say-on-Pay vote every 1 year (46.7M votes); board adopted annual frequency.
- Ratified Grant Thornton as independent auditor for FY2024: 52.7M for, 2.1M against, 2.6K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017024063565/0000950170-24-063565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017024063565/tmci-20240521.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-063565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer